|
|
 |
| |
| |
| ARTICLES |
A Natural Progression
New approaches to cancer research and ways of working offer the promise of exciting developments, says Simon Hadlington.
4/14/2007
Positive Changes for Postdocs
Roshan McArthur finds that while postdoctoral researchers are facing a lack of career opportunities, their prospects are still improving.
3/3/2007
Growth industry
While Illinois may not be as big a player in biotechnology as California or Massachusetts, it's still got plenty to offer, finds Mae Anderson
9/19/2006
The promise of tomorrow
Despite the controversy that surrounds stem cell research, those in the field believe the future is bright, finds Jessie Ron
9/19/2006
An environment for career success
Three scientists working to tackle climate change from very different directions reveal what it takes to Lynn Dicks
9/19/2006
Fast forward
Until recently, microbiology as a discipline seemed to be grinding to a halt. Now, as Bob Holmes finds, there's no stopping it
5/20/2006
Bright lights, big cities
New York and New Jersey are host to some of the most renowned biotechnology centers in the world. And, as Aaron Dalton discovers, they're hungry for new talent
4/15/2006
Know how to beat the odds
Life as a postdoc can be tough, so learn how to play the system and get the most out of the time, says Catherine Zandonella.
3/4/2006
The myths of further study
A PhD can be a huge commitment, so it's important you know the facts. Matthew Killeya asked some of the UK's top scientists to dash a few common misconceptions about life as a postgraduate student
2/18/2006
Mind readers of the 21st century
Alison Motluk looks at a few recent developments in imaging technologies and asks what they are starting to reveal
11/12/2005
Mid-Atlantic starts biotech makeover
At the mouth of the Potomac river sits Washington DC, the political heart of the wealthiest nation on Earth. The region's strong basic research is starting to reflect the shift in the federal government's focus to potential pandemics, bioterrorism and the human genome.
11/5/2005
The hardest path
Despite affirmative action and diversity officers, women and ethnic minorities are still badly under-represented in science. Alison Motluk listened to the stories of four people who made it.
10/15/2005
Recipe for a test tube generation
Young talent is badly needed if the US's chemical industry is to regroup successfully. Tim Lougheed investigates
8/27/2005
Unblocking the drugs pipeline
The pharmaceutical industry needs a shot in the arm. Where will that innovation come from?
8/6/2005
Is it worth the brain-ache?
Just what will a science degree give you - apart from plenty of hard work?
6/25/2005
The next wave
The molecular approach to fighting cancer is starting to deliver the therapies it promised, but there's a long way to go. So where will the field be in 10 years from now? Bob Holmes investigates.
4/9/2005
Welcome to DNA Valley
It is home to the world's premier medical research institutes. But can the Maryland and Washington DC area turn this intellectual clout into a thriving drug-development industry, asks Alison George.
11/13/2004
Protect and prosper
Big spending on biodefence has given research into new vaccines and antivirals a massive shot in the arm. Alison Motluk looks at how US government cash is boosting the prospects for a long-neglected field
10/2/2004
|
|
|
|
Accessibility Options
Login
Register
FEATURED SCIENTIST
Tyrone Hayes, Professor of Integrative Biology at UC Berkeley, is an endocrinologist known for his work on atrazine, a common pesticide used on corn crops. Hayes has found that atrazine causes hermaphrodism in male frogs by causing them to synthesize estrogen, the female hormone.
